Innofamily since 70’s
Paolo Gobbi Frattini Company
Paolo Gobbi Frattini company: Paolo Gobbi Frattini Srl was founded in the 1970s based on the family business where Renzo Gobbi Frattini (father), a pioneer in the automated production of flexible bags and infusion sets, was the creator of major technological innovations with important patents for products and production processes that are still very relevant today.
Over the years, Paolo Gobbi Frattini through the company that bears his name, has founded several other companies as sole partner, including Haemopharm, and has continued the tradition of innovation in the biomedical sector. The company has developed proprietary process machines and holds multiple product patents for drug management through biomedical bags and related accessories.
Production
The Paolo Gobbi Frattini Group manufactures flexible bags for sterile solutions in both PVC and PVC-FREE materials, as well as drug reconstitution and delivery systems and components for advanced therapeutic applications. Raw materials are carefully selected based on strict criteria of biocompatibility with molecules, along with suitable oxygen and vapor barriers. The company stands out for its level of specialization, a continuous commitment to research and development of innovative solutions, with a focus on designing cutting-edge systems and components for drug reconstitution and delivery, many of which are patented. The Paolo Gobbi Frattini Group’s advanced bag systems and their accessories are developed and produced entirely in-house at the Tovo S. Agata (SO) plant in Lombardy, Italy, in compliance with the strictest and highest quality standards.
Proprietary technology of production lines
A key competitive advantage lies is the exclusive, proprietary technology of its production lines, which has been a hallmark of the company since its inception. Modular business management ensures maximum efficiency through versatile, state-of-the-art processes, delivering high product reliability and consistent performance over time.
Direct involvement of ownership in business operations
Paolo Gobbi Frattini holds 100 % ownership of all group companies and is actively involved as CEO, ensuring a long-term perspective. This hands-on approach is a defining aspect of corporate identity, facilitating communication and accelerating decision-making processes, to better meet the clients needs.
The St. Agatha Medical Centre Bridges the Clinic with the Biomedical Industry of the Haemopharm Group
An efficient, state-of-the-art healthcare facility that embodies Haemopharm’s DNA and its commitment to innovation and close collaboration with the medical-scientific community. This center of excellence serves the public, offering ozone therapy as well as outpatient medical and nursing services. Ozone therapy is administered in the clinic using the SANO3 system, produced directly by Haemopharm.
Aliquet adipiscing vivamus ultrices ipsum, commodo vitae, elit nec ipsam luctus. Eget non vitae scelerisque eget sapiente libero, lorem nam quis vitae quis morbi, id consequat mauris massa.
HEAD OFFICE
- Viale Lazio 26, 20135 Milano (MI), Italy
- +39 02 5513513
- info@haemopharm.it
ESTABLISHMENT
- Via Provinciale 8, 23030 Tovo di Sant’Agata (SO), Italy
- +39 0342771017
- info@haemopharm.it
FISCAL INFORMATION
- Company name: Paolo Gobbi Frattini S.r.l.
- Tax code: 09131170962
- Company registration number: 09131170962
- REA Number: MI-2070742
All information contained in this website and about the product described may be changed at any time by Haemopharm Healthcare without notice. Information regarding the specific product in use is only that included in the product packaging.
SANO3 is a patented and CE-marked system produced by Paolo Gobbi Frattini S.r.l. and distributed by Haemopharm Healthcare S.r.l.